8-K: FONAR Appoints Robert M. Carrino as Independent Director, Bolstering Financial Expertise Amidst Growth

FONAR Corporation announced the appointment of Robert M. Carrino, a Certified Public Accountant and partner at CFGI, as an independent director to its Board, filling a vacancy and bolstering the company's financial expertise as it transitions to accelerated filer status.

Summary

• FONAR Corporation appointed Robert M. Carrino as an independent director to its Board of Directors on July 2, 2025.
• Mr. Carrino fills the vacancy left by Ms. Claudette J.V. Chan, who retired on June 19, 2025.
• He is a Certified Public Accountant and a partner at CFGI, LLC, where he leads the firm's SPAC practice and provides complex accounting and consulting services.
• FONAR's primary source of income and growth is its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA).
• HMCA has grown significantly, managing 44 MRI scanners in New York and Florida today, up from 9 in 2009, and completing over 200,000 MRI scans per year.
• The company anticipates Mr. Carrino's extensive public accounting experience, particularly his expertise in healthcare and SPACs, will be invaluable as FONAR transitions into accelerated filer status and pursues business improvement initiatives.
• FONAR is known as "The Inventor of MR Scanning," incorporated in 1978, and developed the unique UPRIGHT Multi-Position MRI, which scans patients in weight-bearing positions.
• The company also has works-in-progress technology for visualizing and quantifying cerebral hydraulics and cerebrospinal fluid (CSF) flow.

Sentiment

Score: 8

Explanation: The document conveys a strong positive sentiment, primarily due to the appointment of a highly qualified independent director whose expertise is explicitly stated to be invaluable for the company's strategic financial transition (accelerated filer status) and business improvement. Additionally, the document highlights significant growth in the company's primary income-generating subsidiary (HMCA) and a commitment to continued growth, along with unique product advantages and ongoing R&D. There are no explicit negatives or risks detailed within the document itself.

Positives

• Appointment of Robert M. Carrino, an independent director with extensive public accounting experience, including healthcare and SPACs.
• Mr. Carrino's expertise is expected to be a tremendous asset, particularly as FONAR transitions into accelerated filer status.
• Significant growth in the Health Management Company of America (HMCA) subsidiary, which manages 44 MRI scanners today compared to 9 in 2009.
• HMCA completes over 200,000 MRI scans per year, indicating strong operational volume.
• Commitment from management to continue growing HMCA for years to come.
• FONAR's unique UPRIGHT Multi-Position MRI technology offers distinct advantages, such as detecting problems missed by lie-down scanners and a near-zero claustrophobic rejection rate.
• Ongoing development of works-in-progress technology for visualizing and quantifying cerebral hydraulics and CSF flow, potentially benefiting patients with neck injuries.

Risks

• The document contains a general forward-looking statement disclaimer that "Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission." No specific risks are detailed within this document.

Future Outlook

FONAR is committed to growing its diagnostic imaging management subsidiary, Health Management Company of America (HMCA), for years to come. The company is also transitioning into accelerated filer status, and expects Mr. Carrino's expertise to be invaluable in this process and in initiatives to improve the business. Additionally, FONAR has works-in-progress technology for visualizing and quantifying cerebral hydraulics and cerebrospinal fluid (CSF) flow, which is expected to benefit patients with whiplash or other neck injuries.

Management Comments

• "Our primary source of income and growth is attributable to our diagnostic imaging management subsidiary, Health Management Company of America (HMCA)."
• "In 2009, HMCA managed 9 MRI scanners; today it manages 44 MRI in New York and Florida that collectively complete over 200,000 MRI scans per year."
• "We are proud of the success of HMCA and are committed to see it grow for years to come."
• "Mr. Carrino's extensive public accounting experience will be a tremendous asset to our organization."
• "His accounting expertise will be an invaluable resource as FONAR is transitioning into accelerated filer status."
• "We are very fortunate to have Mr. Carrino on FONAR's board of directors and we look forward to working with him."

Industry Context

FONAR operates in the medical imaging industry, specifically specializing in MRI technology. It distinguishes itself as "The Inventor of MR Scanning" and by its unique UPRIGHT Multi-Position MRI, which allows for weight-bearing scans and has a high patient acceptance rate due to its open design. The company's primary growth driver is its diagnostic imaging management subsidiary, HMCA, which manages a significant number of MRI scanners, indicating a focus on service delivery within the diagnostic sector. This positions FONAR as both an innovator in MRI technology and a growing provider of diagnostic imaging services.

Comparison to Industry Standards

• No specific comparable companies, projects, or results are mentioned for direct comparison within the document. The document highlights FONAR's unique UPRIGHT Multi-Position MRI technology and its historical role as the inventor of MR scanning, implying a differentiated position rather than direct comparison to standard lie-down MRI manufacturers.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The appointment of an independent director with strong financial and accounting expertise, especially in the context of transitioning to accelerated filer status, could enhance investor confidence in corporate governance and financial reporting quality. The continued growth of HMCA also signals positive operational performance.
• Employees: The focus on business improvement initiatives and continued growth of HMCA suggests stability and potential opportunities within the company.
• Customers: Continued growth of HMCA's managed MRI scanners and the unique benefits of the UPRIGHT MRI (e.g., less claustrophobia, detection of unique problems) indicate ongoing and potentially expanded access to specialized diagnostic services.
• Suppliers: No direct impact mentioned, but continued growth of HMCA could imply increased demand for related supplies and services.
• Creditors: Improved financial oversight and a transition to accelerated filer status could be viewed positively, potentially enhancing the company's financial transparency and stability.

Next Steps

• Continued growth of the Health Management Company of America (HMCA) subsidiary.
• Transitioning FONAR into accelerated filer status.
• Taking initiatives to improve the business, leveraging Mr. Carrino's accounting expertise.
• Further development and potential commercialization of works-in-progress technology for visualizing and quantifying cerebral hydraulics and CSF flow.

Key Dates

Keywords

FONAR, MRI, MR Scanning, UPRIGHT MRI, STAND-UP MRI, Health Management Company of America, HMCA, Diagnostic Imaging, Medical Devices, Corporate Governance, Board of Directors, Independent Director, Robert M. Carrino, SEC Filing, Form 8-K, Healthcare, Accounting, SPAC, Accelerated Filer